[Other] S1204Model-Informed Dosing Interval Extension of Infliximab in Patients With Inflammatory Bowel Diseases: Six Months Interim Analysis of the MODIFI Trial

SaifBawaneh Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-10 00:40
Reward30points

journalㄩAmerican Journal of Gastroenterology

AuthorsㄩZhigang Wang; Ine De Greef; Wannee Kantasiripitak; Sebastian G. Wicha; Sophie Tops; Melissa Nigro; An Outtier; Debby Thomas; S谷verine Vermeire; Marc Ferrante; Erwin Dreesen

Published dateㄩ2024-10-

DOIㄩ10.14309/01.ajg.0001034184.51415.8f

PDF linkㄩhttps://journals.lww.com/10.14309/01.ajg.0001034184.51415.8f

Article linkㄩhttps://doi.org/10.14309/01.ajg.0001034184.51415.8f

Article SourceㄩOvid Technologies (Wolters Kluwer Health)


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    80


Return to the list